Dysphagia is a common feature in patients with parkinsonian syndromes (PS) [1] which include idiopathic Parkinson's disease as well as atypical neurodegenerative Parkinson syndromes. Dysphagia results in significant morbidity by interfering with medication administration, nutrition and fluid intake, and is associated with aspiration pneumonia -the most frequent cause of death in patients with PS [2] . For PS patients presenting with dysphagia, the decision regarding gastrostomy tube insertion (GTI) for feeding is challenging since to date, few studies have addressed the procedural risks and outcomes in this patient population [3] [4] . In contrast, there are already established recommendations for GTI to maintain nutritional support in patients with amyotrophic lateral sclerosis (ALS) that present with severe dysphagia. [5-6-7] . Similarly, the guidelines are established for patients with advanced dementia which do not demonstrate a survival benefit, and consequently the procedure is not recommended. [8] While the utility of GTI in PS patients remains unclear, our study aims to report the indications and outcomes for PS patients that received GTI at two French movement disorders centers, and to highlight any factors affecting these outcomes.
Methods:
All patients with a diagnosis of degenerative PS including idiopathic Parkinson's disease Review Board was waived. We also retrieved the number of PS patients seen at least once per year (caseload) in these centers. Informed consent for gastrostomy tube insertion was obtained from patients, or their relatives where the patient lacked capacity to provide informed consent at the time of gastrostomy insertion.
For each patient, data were extracted from medical records by two neurologists (CM and DG). Nutritional status was recorded according to the current French guidelines (see supplementary methods). Dependence was stratified in three levels based on the Schwab and England activities of daily Living Scale (level 1: completely independent (80-100%), level 2: partially dependent, able to walk (40-70%), level 3: totally dependent (0-30%)). Speech was assessed according to item 18 of the Unified Parkinson Disease Rating Scale (UPDRS).
Cognitive status was documented according to DSM IV criteria. Where possible, the indication for GTI from the clinician's perspective was determined from patient charts and was classified according to one or more of the following categories: undernutrition, impaired swallowing, aspiration pneumonia, inability to take drugs orally or unknown. Short-term adverse-events (AE) were defined as complications that occurred during the gastrostomy procedure or the related hospital stay. AE occurring after hospital discharge were classified as long-term AE. For the survival study, data were censored on the 31th December 2015.
Documented follow-up was available for all included patients for at least one year post-GTI.
The main outcome measure was median survival time post-GTI, estimated by the Kaplan-Meier method. Cox proportional hazards regression analysis was performed to explore predictors of survival post-GTI. Covariates in the Cox regression were chosen among factors that might affect survival post-GTI in patients with a PS according to previous studies and our clinical judgment [9] . These covariates were age at gastrostomy, disease duration, atypical parkinsonism, presence of dementia, under-nutrition and inability to walk. Hazard 
Results:
From January 2008 to December 2014, between 4000 and 4500 PS patients were seen in clinic each year. Of these, approximately ten percent suffered from atypical parkinsonism.
Thirty-three patients were identified as having received gastrostomy tube insertion (mean 
Discussion:
Despite the prevalence of swallowing disorders in patients with PS, very few studies have addressed the utility of GTI in this population. To our best knowledge, this is the first study that specifically describes the current use of gastrostomy in patients with PS, through the experience of two tertiary referral movement disorders centers.
Our study revealed that GTI was mainly utilized in patients with atypical parkinsonism. Of the seven patients with IPD, five presented with very advanced stages of disease and in the two other cases GTI was proposed specifically due to swallowing impairment albeit earlier in the disease course. Of course, the ability to facilitate therapeutic optimization of L-doparesponsive symptoms in IPD patients may have been an additional factor in the clinician's decision to perform GTI, even if not made explicit in the patient charts.
With respect to the primary outcome measure, our cohort demonstrated a strikingly short median survival of 6 months (186 days) following the procedure. This contrasts with ALS patients in two retrospective studies that demonstrated a median survival after GTI of 228 and 327 days respectively [10] [11] . The short survival measured in our cohort may be partly in MSA [12] [13] . Naturally, no conclusions can be drawn as to an effect of GTI on survival owing to the absence of a control group. Identification of retrospective control patients in studies such as this (patients that declined gastrostomy) is difficult, as has been documented in other studies [7] . Furthermore, any attempt at prospective randomization in this particular context raises ethical concerns.
Total dependency before gastrostomy was found to be the only factor independently associated with survival. With small numbers of participants, our study was unlikely to be sufficiently powered to demonstrate associations between survival and other factors measured such as age, disease duration and the presence of dementia.
The most frequent complication recorded was aspiration pneumonia which occurred in half of the patients and lends weight to the prevailing view that GTI does not prevent aspiration.
Interestingly, preventing aspiration pneumonia was the main indication from clinician's perspective for 34 % of our patients.
Given that dysphagia in PS is common, the small number of GTI procedures undertaken in our study centers was surprisingly low in comparison with our large case load [1] . This may be either the result of clinicians' reluctance to propose GTI to this population given the uncertainties regarding the risks and benefits, patients or relatives' refusal of these invasive techniques or a combination of both. As emphasized previously, no guidelines endorse these procedures in PS patients. Furthermore, advance care planning is rarely discussed in relative slowly progressive diseases such as PS [14] .
Our study presents several limits, mainly due to its retrospective nature. Incomplete information was available about patients' nutritional status after gastrostomy, so we could not draw any conclusions regarding the nutritional efficacy of GTI in PS. Another shortcoming is the lack of quality-of-life data for patients and caregivers following M A N U S C R I P T
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Marois 10 gastrostomy which, in a setting where survival may not be the primary goal, is crucial to guide future clinical decisions. As randomization is not conceivable in this context, these complex issues should be at best addressed in future research with mixed methods (both quantitative and qualitative). Finally, this study, performed at two French movement disorders centers, may reflect a regionally-specific practice and thus, not be generalized to the broader PS population.
In conclusion, this study is one of the first to give specific insight into outcomes of GTI in PS.
According to our results, ambulant patients are more likely to benefit from the procedure. A larger prospective study is warranted to assess the potential benefits of gastrostomy in terms of quality of life and nutritional efficacy, as well as to identify the most appropriate indications and timing for the procedure. This future research will enable clinicians and patients to discuss choices in an advance care planning setting with reference to an adequate evidence-base. 
Highlights
-This is a retrospective study conducted on 33 patients -We investigated the outcome of gastrostomy tube insertion in Parkinsonian syndromes.
-The median survival following the gastrostomy tube insertion was 6 months.
-Being totally dependent was associated with a shorter survival.
-Aspiration pneumonia is no prevented by gastrostomy tube insertion.
